Several mechanisms may lead to increased expression of insulin-like growth factor-2 (IGF2) in patients with BWS, and IGF2 has been associated with tumorigenesis in various breast tumors [5]; however, few reports have described fibroadenomas in patients with BWS [2–7]. This evidence concerns the gene IGF2 and Beckwith-Wiedemann syndrome.